ArticleCureus2024
Drug-Induced Oral Erythema Multiforme: A Report of a Rare Case.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Viral-Induced Erythema Multiforme Complicated by Secondary Bacterial Infection with Hyperpyrexia Following Cervical Spine Surgery: A Rare Case of Dual Infection.Infection and drug resistance · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erythema multiforme (EM) is an acute-onset, self-limiting inflammatory condition affecting the skin and mucous membranes. It exhibits a range of skin lesions, which is why it is referred to as "multiforme." Oral lesions, usually inflammatory and frequently marked by rapidly rupturing vesicles and bullae, often constitute a significant clinical feature. The exact etiology is obscure; however, it may be caused by multiple triggering factors. The most well-established connection is with a previous herpes simplex virus infection, while a smaller percentage of cases (<10%) are linked to drug use. Based on mucosal involvement, the condition is classified into two types: EM minor and EM major. Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's disease) are now recognized as separate clinical conditions. EM usually exhibits a self-limiting course, with lesions typically improving within a few weeks. Avoiding triggers and using steroid therapy can be effective treatments. This paper documents a rare case of drug-induced oral EM featuring characteristic lip and intraoral lesions. The patient developed painful oral ulcers and difficulty in swallowing after taking azithromycin for a sore throat and fever. Clinical examination revealed multiple, hemorrhagic encrustations on the lips, along with ulcers on the right buccal mucosa and vesicular eruptions on the palate. The acute onset of multiple oral ulcers associated with a recent drug intake led to a diagnosis of drug-induced oral EM. Treatment included systemic prednisolone, topical triamcinolone paste, and supportive oral care. No recurrence was observed during the six-month follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.